This article is more than 5 years old. Information may no longer be current.
Coffee intake led to short-term rise in BP for patients with hypertension
Click Here to Manage Email Alerts
American Society of Hypertension 2011 Annual Scientific Meeting
NEW YORK — In a new meta-analysis, consumption of coffee among patients with hypertension resulted in acute increases in BP up to 3 hours after intake, suggesting that drinking the beverage before clinical checkups may influence BP measurements. However, no long-term effects were reported.
According to Esther Lopez-Garcia, PhD, of the Autonomous University of Madrid, Spain, who presented findings from the analysis, the association between coffee/caffeine and BP among those with normal BP has been widely studied and reported in clinical trials, which have consistently indicated an acute increase after consumption. Despite this, the effect on patients with hypertension remains uncertain, Lopez-Garcia said.
She and colleagues examined five trials that looked at administration of 200 mg to 300 mg of caffeine, or 1.5 to two cups of filtered coffee, in those with hypertension.
In all, consumption of caffeine increased the mean systolic BP by 8.2 mm Hg and mean diastolic BP by 5.6 mm Hg, which was reported in the first hour and lasted until at least 3 hours later. These results did not change, even if there was a duration of caffeine abstinence before the trial or if the patient was taking antihypertensive medication.
However, none of the trials found an association between habitual coffee consumption and an increased risk for CHD or stroke, leading Lopez-Garcia to conclude that the effects among patients with hypertension appear similar to normotensive patients.
“Consumption of coffee or caffeinated beverages may alter BP measurements in routine checkups,” she said in her presentation regarding the implications of the study. “In those with BP well-controlled, it may be safe to consume coffee. For patients with uncontrolled BP, moderation in coffee consumption is suggested.” – by Brian Ellis
Disclosure: Dr. Lopez-Garcia reports no relevant financial disclosures.
For more information:
- Mesas A. PO-67. Presented at: American Society of Hypertension 2011 Annual Scientific Meeting and Exposition; May 21-24, 2011; New York.
 |
Follow CardiologyToday.com on Twitter. |